Which has the lower trailing P/E, DXCM or LH?

LH has the lower trailing P/E: DXCM trades at 29.46 and LH at 26.10. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or LH?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus LH at -2.62%.

Does DXCM or LH pay a bigger dividend?

LH pays a dividend (0.91% yield), while DXCM has no payments in the available dividend history.

Is DXCM or LH more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus LH at 6.99%.

How have DXCM and LH total returns compared?

Over the past 10 years, DXCM delivered 12.45% and LH delivered 10.73% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs Labcorp Holdings Inc. (LH)

A side-by-side comparison of DexCom, Inc. and Labcorp Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$28.76B

$74.54HealthcareDelayed quote: Jul 30, 2026, 4:00 PM EDT

Labcorp Holdings Inc.

$25.87B

$315.53HealthcareDelayed quote: Jul 30, 2026, 4:00 PM EDT

Total return — DXCM vs LH

growth of $100 · dividends reinvested · last 21y

DXCM +2435.4%LH +695.9%DXCM compounded faster

DXCM LH

DXCM vs LH: by the numbers

•DXCM is the larger company ($28.76B vs $25.87B market cap).
•LH trades at the lower trailing earnings multiple (26.10 vs 29.46 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 6.99% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs -2.62% CAGR).
•LH pays a dividend (0.91% yield), while DXCM has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DXCM	LH
P/E ratio	29.46	26.10
Forward P/E	28.75	17.51
P/S ratio	5.88	1.81
P/B ratio	11.14	3.02
PEG ratio	0.67	1.28
EV / EBITDA	23.22	16.69
FCF yield	4.81%	4.44%

Profitability

Metric	DXCM	LH
Gross margin	62.79%	28.38%
Operating margin	22.92%	11.23%
Net margin	20.12%	6.99%
ROE	38.14%	11.65%
ROIC	16.61%	7.39%

Dividends

Metric	DXCM	LH
Dividend yield	N/A	0.91%
Payout ratio	N/A	27.32%

Growth (annualized)

Metric	DXCM	LH
Revenue CAGR (5Y)	18.03%	-2.62%
EPS CAGR (5Y)	10.31%	-8.00%
FCF CAGR (5Y)	69.49%	-16.45%
Total return CAGR (5Y)	-10.37%	5.48%

Frequently asked

Which has the lower trailing P/E, DXCM or LH?: LH has the lower trailing P/E: DXCM trades at 29.46 and LH at 26.10. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or LH?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus LH at -2.62%.
Does DXCM or LH pay a bigger dividend?: LH pays a dividend (0.91% yield), while DXCM has no payments in the available dividend history.
Is DXCM or LH more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus LH at 6.99%.
How have DXCM and LH total returns compared?: Over the past 10 years, DXCM delivered 12.45% and LH delivered 10.73% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full LH analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Labcorp P/E ratio DexCom dividend yield Labcorp dividend yield DexCom ROE Labcorp ROE DexCom operating margin Labcorp operating margin DexCom revenue growth Labcorp revenue growth DexCom free cash flow Labcorp free cash flow

DexCom & Labcorp appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.